Ticagrelor-Induced complete heart block: A rare entity

Wagle Varun Anand, Isha Khadke, R. Padmakumar, M. Sudhakar Rao, Bharti Chogtu

Research output: Contribution to journalArticlepeer-review


Ticagrelor, a purinergic P2Y12 receptor blocker, is a potent platelet antagonist and an important component in the treatment for acute coronary syndromes identified to have a potential risk to cause bradyarrhythmias. Here, we report the case of a diabetic patient of unstable angina with left bundle branch block who was prescribed ticagrelor post angioplasty. Electrocardiogram (ECG) revealed a complete heart block after about 1 week. Ticagrelor was stopped and replaced by clopidogrel. The patient became asymptomatic and ECG showed baseline rhythm after 1 week of stoppage of ticagrelor.

Original languageEnglish
Pages (from-to)75-77
Number of pages3
JournalJournal of Pharmacology and Pharmacotherapeutics
Issue number2
Publication statusPublished - 01-04-2020

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmacology (medical)


Dive into the research topics of 'Ticagrelor-Induced complete heart block: A rare entity'. Together they form a unique fingerprint.

Cite this